Biosense Webster/Stereotaxis ablation combination
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Biosense Webster's NaviStar and Celsius RMT steerable tip diagnostic/ablation catheters, approved for use with Stereotaxis' Niobe magnetic navigation system by FDA Feb. 7, will enable doctors "to steer a catheter remotely, map the electrical activity of the heart and ablate targeted areas" in patients with cardiac arrhythmias, according to the firm. Stereotaxis has touted its device as bringing value to complex cardiology and electrophysiology interventions (1"The Gray Sheet" Sept. 27, 2004, p. 12)...